How Orange Book Antitrust Scrutiny Is Intensifying
By Elai Katz, Lisa Rumin and Betty Zhang · July 29, 2024, 1:44 PM EDT
Pharmaceutical patent holders beware: Over the past year, antitrust enforcers have taken a more aggressive approach challenging Orange Book listings as an anticompetitive practice....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login